GOSSAMER BIO, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -192.7% | -155.4% | -68.1% |
| FY2022 | -1,899.3% | -953.2% | -84.2% |
| FY2023 | -286.5% | -282.8% | -57.6% |
| FY2024 | -191.7% | -191.7% | -17.9% |
| FY2025 | 138.8% | 138.8% | -98.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -192.7% | -155.4% | -68.1% |
| FY2022 | -1,899.3% | -953.2% | -84.2% |
| FY2023 | -286.5% | -282.8% | -57.6% |
| FY2024 | -191.7% | -191.7% | -17.9% |
| FY2025 | 138.8% | 138.8% | -98.9% |